0ZDBLOGGINGDBOBJSDEFFORMFLDNAMESINDEX0INDEX55WSFIELDS0r/1}1X r/1r/1 *! '%&3B.& -%% /17%J+#"( (R80@T-AAAAAAAAAAAAAAAAADKCn`AAAAAAAAAAAAAAAAACMI.AAAAAAAAAAAAAAAAACMGAAAAAAAAAAAAAAAAACMHPAAAAAAAAAAAAAAAAADOGAAAAAAAAAAAAAAAAADGBAAAAAAAAAAAAAAAAAAATAAAAAAAAAAAAAAAAABOHAAAAAAAAAAAAAAAAABOIAAAAAAAAAAAAAAAAACDVAAAAAAAAAAAAAAAAACHNAAAAAAAAAAAAAAAAACJQAAAAAAAAAAAAAAAAACYZAAAAAAAAAAAAAAAAACZJAAAAAAAAAAAAAAAAADAPAAAAAAAAAAAAAAAAAEEMAAAAAAAAAAAAAAAAAFHCAAAAAAAAAAAAAAAAAFHKAAAAAAAAAAAAAAAAAFHLAAAAAAAAAAAAAAAAAGFFAAAAAAAAAAAAAAAAACFR rAAAAAAAAAAAAAAAAADMY AAAAAAAAAAAAAAAAAGMOAAAAAAAAAAAAAAAAAFLWAAAAAAAAAAAAAAAAAAKB AAAAAAAAAAAAAAAAABVA AAAAAAAAAAAAAAAAACAT AAAAAAAAAAAAAAAAACZT AAAAAAAAAAAAAAAAADDI AAAAAAAAAAAAAAAAABZQ AAAAAAAAAAAAAAAAAAJS %AAAAAAAAAAAAAAAAACJV]AAAAAAAAAAAAAAAAADHB0jr/1}16 6 6 66 6 6 6 66 6 6 6 66 86 6 6 6 6 6 6 6 6 6 :6 6 6 6 23\$x@ ` ( H f .  N  n 6 v && 0@          P                       $                      $                       $       6 6 6 66 6 6 6 6 6 > 6 6 6 6 6 6 6 @ 6 6 6 6 6 6 6 B 6 6 6 6 6 6 6 ;V* <= 6 >7?@A B C D E  F  G %H  I:JOKdLyMNOPQRS T!U6VKW`Xn  ?W$ ?W$ ?W$lzVv>Rr:Pp0Pp8f ''&2'   . / ","-"."/"&&&.&/&(,(-(.(/(,,,.,/,.,.-.../.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}1,.06 26 6 26 6 6 46 6 6 46 :6 6 6 6 6 :6 6 6 6 6 6 :6 6 6 6 6 6 :6 6 6 6 6 6 :6 6 6 6 6 6 :HPLCp4T p 8 X  t <  X x @ \$xB d,PzJ  77x<6 6 6 6 6 6 < 6 6 6 6 6 6 < 6 6 6 6 6 6 < 6 6 6 6 6 6 > 6 15Tartaric acidHPLC OA-5000 50 x 4.6 mm[1mM copper (II) acetate and 0.05M ammonium acetate in water/isopropanol (85:5) [pH 4.5] UV-280 nmRoom Temperature 1:Sumichiral OA and Sumichiral Technical News (Vol. 9808)6.448.2 (L) and 12.3 (meso)m 1.5 (D)58calpha,alpha'-bis[3-(N-benzyl-N-methyl-carbamoyl)-piperidino]-p-xylene dihydrobromide (Ref. n82) HPLC Chiral-AGP 5h100 x 4.0 mm -=10% ethanol in 0.025% sod. ph. b. pH 7.0 + 0.025M TBA.HSO4 ( UV-220 nm *Chrom Tech Application Note n13 (1994) 27 @0,9 17,5 @19 UV-240 nm *Chrom Tech Application Note n13 (1994) 4.83 (-) 0,9 3.74 (+) 191,28 ?W$7          IEHJGF ?W00   9   :;=<>@CB?AD ?W0002475001201001208001213RI1,03 AAAAAAAAAAAAAAAAADQWt@mnLOi@& ()*+,./524-36 ?U04 48 /1(: V15 5 4 *  | `  R h v &    ~flVL B tP XJn B N x8X r:Zt<Vv> :  OOFb2-(4,5-dihydro-1H-imidazol-2-yl)-2-propyl-1,2,3,4-tetrahydropyrrolo[3,2,1-hl]-indole (Ref.n63) HPLC Chiral-AGP 5100 x 4.0 mm *10% acetonitrile in 0.05M KH2PO4 pH 6.1 Epibatine (Ref. n106) HPLC Chiral-AGP 5100 x 4.0 mm r3% acetonitrile in 10mM disodiumphosph. b. + 5mM pentane sulphonic acid adj. to pH 7.4 with ortho-phosph. acid UV-215 nm 0,9 2,32 13392-18-2 54910-89-3 54910-89-3 5104-49-4 58-05-9 118-42-3 15687-27-1 31842-01-0 303-14-0 22071-15-4 36894-69-6 50-12-4t 115-38-8 113-45-1 98-84-0 6843-49-8 6843-49-8 37350-58-6 24219-97-4 22204-53-1 55985-32-5 86-34-0A 90319-52-1 13523-86-9 6620-60-6n 60-87-7 525-66-6 3930-20-9z 23031-25-6 4756-92-7F 50-35-1J 739-71-9 81-81-2xsaXY Arialx 0 a!  E@DC%! nXEDC% '!  EDN% '! EDC% '! # E@DO% '! E DO% ' ( 56-41-7#F$++)@+q !J  &!a JaXY Arialx 0a! DDN%! #DDC% '! DDC% '! DDN% '! DDN% '(! F^DDC% ' ! f EDC% ' ! FEDC% ' ! EDC % ' ! i*EDO % '! EߛDO % '(! FEDN % ' )@ 74-79-3?!"$d sQ UZIZMM`Qy`M`z`QlOWZXZ`J!M a^M 70-47-3 aXY Arialx 0a! gEDN%! #/(E`DC% '! 2EDC% '! F=E_DC% '! ؅HEDC % '! i=SE_DO % ' ! ׅHEDO % ' (! F=E?DN % ' )! #/(E DO % '(3"#CbsІ&32&gж72!>=T1a HF> 56-84-8C!DJ ta N\)\JbLibMOLnn;b u8\ugbnA 7424-00-2C!EJDŽ bQ i-ok]ip-[|o|ӷ*i։|p*;hQ 372-75-8 3395-35-5i 63-84-3h 56-86-035!"$ty_n_瘙&nv_x—'Xc! <'aF- AAAAAAAAAAAAAAAAADQXIt!)KqUY@-21,830 T F pd\8,$XL@4& vh\PD8*d~nD8  MMLaXY Arialx 0a! PEDC%! E`DC% '! 0D`DC% '! DDO% '! 0DDO% '(! #EDC% ' ! EDN% ' ! #EDO% ' (! v'E`DO % '  1"#DuxP|ԗ|uq! ? A C D E G @ B F  #U0 AAAAAAAAAAAAAAAAAFHS#`8N r@' ) * .+ . . ., - . 0 2 3 7 4 6 / 1 5 8 ?U05 8 t d : 2 "  ~    j b V N F @0$FPvn^X&PD<zrN GGTxArialPArialPDbit (ml/min)y Root>Debit ArialP@z@ACDEv ArialxFGHIJKLMNOB :x x zp   7 [!ArialxArialPArialPVitesse (cm/s) / Split ratioyRoot>Vit/ratio ArialP@z@ACDEv ArialxFGHIJKLMNOB :x K    8 [ !ArialxArialPArialPDtectionyRoot>Detection ArialP@z@ACDEv ArialxFGHIJKLMNOB :x ,   9 [!ArialxArialPArialPRsy Root>Rs ArialP@z@ACDEv ArialxFGHIJKLMNOB :x    : [!ArialxSymbolxSymbolxay Root>Alpha ArialP@z@ACDEv ArialxFGHIJKLMNOB :x z- ^   ; [ !ArialxArialPArialPt0 (min)y Root>t0 ArialP@z@ACDEv ArialxFGHIJKLMNOB :x z-    < [ !ArialxArialPArialPtR2 (min)y Root>t2 ArialP@z@ACDEv ArialxFGHIJKLMNOB :x z-    = [ !ArialxArialPArialPtR1 (min)y Root>t1 ArialP@z@ACDEv ArialxFGHIJKLMNOB :x +   > [!ArialxArialPArialPk'1y Root>k1 ArialP@z@ACDEv ArialxFGHIJKLMNOB :x +   ? [!ArialxArialPArialPk'2y Root>k2 ArialP@z@ACDEv ArialxFGHIJKLMNOB :x    @ [ !ArialxArialPCommentairesy Root>Com ArialP@zB   , [ ArialdArialxArialdpyrazoley Root>pyrazole ArialP@z@ACDEv ArialxFGHIJKLMNOB :x Z   - [ ArialdArialxArialdpyrrolidineyRoot>pyrrolidine ArialP@z@ACDEv ArialxFGHIJKLMNOB :x 8 C   . [ ArialdArialxArialdpiperidineyRoot>piperidine ArialP@z@ACDEv ArialxFGHIJKLMNOB :x ^ 4   / [ ArialdArialxArialdpiperazineyRoot>piperazine ArialP@z@ACDEv ArialxFGHIJKLMNOB :x <H   0 [ ArialdArialxArialdmorpholineyRoot>morpholine ArialP@z@ACDEv ArialxFGHIJKLMNOB :x      1 [!ArialxArialPArialPType de chromatographiey Root>tc ArialP@z@ACDEv ArialxFGHIJKLMNOB :x hVM   2 [!ArialxArialPArialPParticules (m)yRoot>Particules ArialP@z@ACDEv ArialxFGHIJKLMNOB :x hME   3 [ !ArialxArialPArialPDimensionsy Root>Dimcol ArialP@z@ACDEv ArialxFGHIJKLMNOB :x n`{   4 [ !ArialxArialPArialPPhase mobileyRoot>Phase_mobile ArialP@z@ACDEv ArialxFGHIJKLMNOB :x aE    5 [!ArialxArialPTemprature (C)y Root>Temp ArialP@z@ACDEv ArialxFGHIJKLMNOB :x x {pz   6 [!Arial  :6 6 6 6 6 6 6 6 6 6 6 D 6 6 D 6 6 6 6 6 6 6 6 D 6 6 6 6 6 6 6 6 D D 6 6 6 6 6 6 6 6 D 6 6 6 6 6 6 6 6 D 6 6 6 6 6 6 6 6 D 6 6 6 6 6 6 21Tt< N  n 6 H  h 0 z B b*f.N`(H"l4Z Tt< EEZEv ArialxFGHIJKLMNOB :x a   " [ ArialdArialxArialdpyrimidineyRoot>pyrimidine ArialP@z@ACDEv ArialxFGHIJKLMNOB :x a   # [ArialdArialxArialdpyrroley Root>pyrrole ArialP@z@ACDEv ArialxFGHIJKLMNOB :x <_   $ [ ArialdArialxArialdisoxazoleyRoot>isoxazole ArialP@z@ACDEv ArialxFGHIJKLMNOB :x K   % [ArialdArialxArialdfurany Root>furan ArialP@z@ACDEv ArialxFGHIJKLMNOB :x RtO   & [ ArialdArialxArialdthiopheneyRoot>thiophene ArialP@z@ACDEv ArialxFGHIJKLMNOB :x i   ' [ ArialdArialxArialdpyridiney Root>pyridine ArialP@z@ACDEv ArialxFGHIJKLMNOB :x Z|n   ( [ ArialdArialxArialdquinolineyRoot>quinoline ArialP@z@ACDEv ArialxFGHIJKLMNOB :x Rf m!   ) [ ArialdArialxArialdthiadiazoleyRoot>thiadiazole ArialP@z@ACDEv ArialxFGHIJKLMNOB :x Z8 e   * [ ArialdArialxArialdthiazoley Root>thiazole ArialP@z@ACDEv ArialxFGHIJKLMNOB :x !C   + [ ArialdArialxArialdcoumariny Root>coumarin ArialP@z@ACDEv ArialxFGHIJKLMNOB :x i) / 6 6 6 6 6 6 6 6 6 6 6 6 6 6 D 6 6 6 6 6 6 6 6 F 6 6 6 6 6 6 6 6 H 6 L 6 6 6 6 6 6 6 6 6 N 6 6 6 6 6 6 6 6 6 6 6 6 P 6 6 6 6 6 6 6 6 6 6 3X x@ ` ( f . N  n 6 v >  ^&hv>^n6Vh0Pp8 EE^6 6 6 6 6 6 6 6 6 6 J 6 6 6 6 6 6 6 6 6 6 6 6 R 6 6 6 6 6 6 6 6 6 6 <=>?@ABCDEFGHIJK L!M"N#O$P%Q &R 'S (T )U,Kromasil chiral phases - Application guide'H ?W$ ?W$ ?W$ ?W$ ?W$vhLZph0Ppt\$|0Pp<8 **6 6 6 6 6 6 6 T 6 6 6 C:\ISIS20\chromchir.dbRootIDcode structure *structurenomprix quantitcasqt2prix2qt3prix3boronicpuretamine1bocnitros carboxyliccbz nitriles aldehydesketones alcoholsamidesamines2 hydrazines isocyanatesisothiocyanatessulfonylhalides thioamidesthiolsfmoc hydrazidesbenzothiophene imidazoleindole pyrimidinepyrrole isoxazolefuran thiophene pyridine quinoline thiadiazole thiazole piperidine piperazine coumarin pyrazole pyrrolidine morpholine*fmla_structure*mol.weight_structure*ctab_structure*keys_structure*exact_structureC:\ISIS20\chromchir.dbC:\ISIS20\chromchir.dbtcC:\Charlotte\chromchir.dbC:\Charlotte\chromchir.dbNom_col ParticulesDimcolRefcol Phase_mobileDebit Detection Vit/RatioTempRst0k1k2alphat1t2RefdocPageAlpha Vit/ratiot2ComC:\Charlotte\Chromchir.dbC:\Charlotte\Chromchir.dbRefcolDebitRst0k1k2t1PageAcenocoumarolHPLCKromasil CHI-II5 250x4,6mm*Hexane/2-Propanol/Acetic acid (93/7/0,1) UV 254 nm,Kromasil chiral phases - Application guide1,1427,831,54 AAAAAAAAAAAAAAAAAAAA'|`h2Zv@#/.,+*)('%"#&$!&? %-E;:9876412530 ?W$ ?W$ ?W$ ?W$ ?W$ ?W$ ?W$ ?W$ ?W$131 tfXJ<.  . @ H \ b p d NPp8 ''6 6 6 6 6 6 6 6 6 6 6 6  uY!Z"[ #\!$]"%^#&_$'`%(a&)2b'*Gc(+\d),qe*-f+.g,/h-0 i.1 j/2k03l14m25n38o49p5:q6tu7xy8 z{9 |}: ~;BaclophenlactamHPLCKromasil CHI-II5 250x4,6mmHexane/2-Propanol (95/5) UV 254 nm,Kromasil chiral phases - Application guide1,5124,532,01 AAAAAAAAAAAAAAAAAAABT`Ath@& Q%     $   8 x  "  * D0 h0Pp8 BaclophenlactameSFCKromasil CHI-II15 250x4,6mm *CO2 + 2-Propanol (10%), 40OA-C, 150 barsUV 240, 272 nm,Kromasil chiral phases - Application guide1,1923,313BendroflumethazidHPLCKromasil CHI-IIs5n 250x4,6mme5Hexane/2-Propanol/tert-Butylmethyl ether (60/10/30) UV 254 nmn,Kromasil chiral phases - Application guide1,1823,473BenoxaprofenHPLCKromasil CHI-IIe5o 250x4,6mmt7Hexane/tert-Butylmethyl ether/Acetic acid (60/40/0,1) UV 310 nm,,Kromasil chiral phases - Application guide1,7222,04431-Benzoyl-2-tert-butyl-3-methyl-4-imidazolidinoneHPLCKromasil CHI-I5C 250x4,6mmHexane/2-Propanol (98/2) UV 254 nm1,5722,5441,81 AAAAAAAAAAAAAAAAAAACT`Ath@ AAAAAAAAAAAAAAAAAAADtHg6Vz@ AAAAAAAAAAAAAAAAAAAE!d`8&r@ AAAAAAAAAAAAAAAAAAAF(CkEp@000004000006 06Dp2V&JX> `fX*nJ `t  6<<j Binaphtol HPLCKromasil CHI-I5 250x4,6mm Hexane/2-Propanol (95/5) UV 254 nm ,Kromasil chiral phases - Application guide1,992 2,064 BupivacaineHPLCKromasil CHI-II5 250x4,6mm=Hexane/2-Propanol/Acetic acid/Triethylamine (99/1/0,3/0,05) UV 240 nm,Kromasil chiral phases - Application guide1,622,584 CamazepamHPLCKromasil CHI-II5 250x4,6mm4Hexane/tert-Butylmethyl ether/2-propanol (80/20/1) UV 254 nm,Kromasil chiral phases - Application guide1,2524,3452,72 AAAAAAAAAAAAAAAAAAAG)t@@RDUq@ AAAAAAAAAAAAAAAAAAAH%72r@ AAAAAAAAAAAAAAAAAAAI'8Hh9=w@( @H          000008)              * @t "    # $ % & ' ) , + ( * - "2 "   """"" " " " " """""""""""""""""""" ?W$ ?W$ ?W$ ?W$ ?W$ ?W$ ?W$ ?W$ ?W$RI$T`RD6( B N 8F@nt >lz0t. h.\(<Xf8 89 t Carprofen HPLCKromasil CHI-II 5 250x4,6mm .tert-Butylmethyl ether/Acetic acid (100/0,1) UV 300 nm ,Kromasil chiral phases - Application guide1,632 1,565 CarticaineHPLCKromasil CHI-II 5 250x4,6mm =Hexane/2-Propanol/Acetic acid/Triethylamine (98/1/0,3/0,05) UV 280 nm ,Kromasil chiral phases - Application guide1,242 4,985 ChlormezanoneiHPLCKromasil CHI-I5 250x4,6mm Hexane/2-Propanol (85/15) UV 254 nmA,Kromasil chiral phases - Application guide1,1723,035,Kromasil chiral phases - Application guide1,51 AAAAAAAAAAAAAAAAAAAJd`(=Њq@ AAAAAAAAAAAAAAAAAAAK8؁sFq@ AAAAAAAAAAAAAAAAAAALd`88-xq@000011 "6" """"!"""#"$"%"'"*")"&"("+"!$#$$$$$$$$$$ $ $ $ $ $$"$$$$$$$$$$$$$$$$$$#$&$&&& $!$"$#$$$&$)$($%$'$*$$+$,$ "-$ " " ".$/$0$1$2$4$0"6$3$5$7$ ?W$ ?W$ ?W$ ?W$ ?W$HPLC ?W$jTF8*Rn  d L6D>b RD |n>0* 67xp-Chlorophenprocoumon HPLCKromasil CHI-II 5 250x4,6mm DHexane/2-propanol/tert-Butylmethyl ether/Acetic acid (65/5/30/0,3) UV 310 nm ,Kromasil chiral phases - Application guide1,242 5,596 Chlorthalidon HPLCKromasil CHI-I5 250x4,6mm Hexane/2-Propanol (95/5) UV 254 nm ,Kromasil chiral phases - Application guide1,6 2 3,416 ChlorthalidonSFC4Kromasil CHI-II 5C 250x4,6mmC*CO2 + 2-Propanol (10%), 40OA-C, 150 barsUV 240, 272 nm,Kromasil chiral phases - Application guide1,5@2 14,82,6@ Clenbuterol@HPLCKromasil CHI-IIg5 250x4,6mm<Hexane/2-Propanol/Acetic acid/Triethylamine (95/5/0,2/0,1) UV 300 nm,1,232C1,7763 AAAAAAAAAAAAAAAAAAAM%|1Ws@C AAAAAAAAAAAAAAAAAAAN\H+Y,u@C AAAAAAAAAAAAAAAAAAAO\H+Y,u@C AAAAAAAAAAAAAAAAAAAP ܀#Sq@C000014000016 ?W$ ?W$$CbT xhJ4 bJX R( RD(@J<6" 79p(1,5-Dimethyl-4-phenyl-2-imidazolidioneHPLCKromasil CHI-I5 250x4,6mm Hexane/2-Propanol (98/2) UV 254 nm ,Kromasil chiral phases - Application guide1,132 3,097 EpithiazidHPLCKromasil CHI-I5 250x4,6mm4Hexane/2-propanol/tert-Butylmethyl ether (60/5/35) UV 254 nm,Kromasil chiral phases - Application guide1,2423,617 EtodolacHPLCKromasil CHI-II5 250x4,6mm7Hexane/tert-Butylmethyl ether/Acetic acid (75/25/0,1) UV 270 nm,Kromasil chiral phases - Application guide1,252@2,9172,33 AAAAAAAAAAAAAAAAAAAQt1dug@ AAAAAAAAAAAAAAAAAAAR\H\ Fz@ AAAAAAAAAAAAAAAAAAAS#`8q@%&&&&&&&&&& & && & & &&000018&&&(&(((&&&&&&&&&&&0 & ("&(((#&$&%&&&'&)&,&+&(&*&-&1 ( @ &( & & &((((( ( ( ( ( ((2 ((*(***((((((((((( ?W$ ?W$ ?W$ ?U0 ?U0 ?U0 ?U0 ?U0RI0dbTF8*R ^HV Pp Lz>> xH tXJD2*l 78vFlurbiprofenHPLCKromasil CHI-II 5 250x4,6mm 7Hexane/tert-Butylmethyl ether/Acetic acid (60/40/0,1) UV 270 nm ,Kromasil chiral phases - Application guide1,732 1,5 7 HexobarbitalHPLCKromasil CHI-I5 250x4,6mm Hexane/2-Propanol (95/5) UV 254 nm ,Kromasil chiral phases - Application guide1,192 1,8 8 Ibuprofen HPLCKromasil CHI-II 5 250x4,6mm 7Hexane/tert-Butylmethyl ether/Acetic acid (75/25/0,1) UV 220 nmA,Kromasil chiral phases - Application guide1,7621,54810,9 AAAAAAAAAAAAAAAAAAATl@n@ AAAAAAAAAAAAAAAAAAAU8M»m@ AAAAAAAAAAAAAAAAAAAV@0i@0000213 (J  (  !("(#($(%('(*()(&(((+(4 *R********** * * * * **5 **,*,,,***********6 *b,*,,, *!*"*#*$*&*)*(*%*'***7 +*,*.-*....*/*0*1*2*4*7*6*3*5*8* ?U0 ?W0 ?W0 ?W0 ?U0 ?W0 ?W08 ?W0 ?W00T(XD f6B 8 N 8F@Rt ~:hv,p hz@2,\ 89t IndapamideHPLCKromasil CHI-I5 250x4,6mm +Hexane/2-Propanol/Acetic acid (80/20/0,1) UV 254 nm ,Kromasil chiral phases - Application guide1,252 2,988 Ketazolam HPLCKromasil CHI-I5 250x4,6mm Hexane/2-Propanol (90/10) UV 254 nm ,Kromasil chiral phases - Application guide1,272 2,828 KetoprofenHPLCKromasil CHI-IIm5@ 250x4,6mma7Hexane/tert-Butylmethyl ether/Acetic acid (60/40/0,1)p UV 250 nme,Kromasil chiral phases - Application guide1,252 2,539 Lopirazepam HPLCKromasil CHI-II5 250x4,6mm5Hexane/tert-Butylmethyl ether/2-propanol (50/40/10) UV 240 nmI,Kromasil chiral phases - Application guide1,572I3,23912,19 AAAAAAAAAAAAAAAAAAAW!8Kuv@ AAAAAAAAAAAAAAAAAAAX)8zk`+ w@ AAAAAAAAAAAAAAAAAAAY!tkC8o@ AAAAAAAAAAAAAAAAAAAZL( 1q"t@000024000026 ?U00bvp\TDXB >(60t6 n*Xf`N*xj<.( 8:p Lorazepam HPLCKromasil CHI-II 5 250x4,6mm 5Hexane/tert-Butylmethyl ether/2-propanol (50/40/10) UV 254 nm ,Kromasil chiral phases - Application guide1,6 2 1,889 MefloquineHPLCKromasil CHI-I5 250x4,6mm<Hexane/2-Propanol/Acetic acid/Triethylamine (95/5/0,1/0,1) UV 280 nm,Kromasil chiral phases - Application guide1,4723,849 MephenytoinHPLCKromasil CHI-I5 250x4,6mmHexane/2-Propanol (95/5) UV 230 nm,Kromasil chiral phases - Application guide1,3321,93101,12 AAAAAAAAAAAAAAAAAABAT( Stt@ AAAAAAAAAAAAAAAAAABB#@<~ow@ AAAAAAAAAAAAAAAAAABCt(Qi>Hk@8 ,.,...,,,, , ,, , , ,,0000281",,0,000,,,,,,,,,,,2" ,0",000#,$,%,&,',),,,+,(,*,-,3".2.222..... . . . . ..4".. .  ............ ?U0 ?U0 ?U0 ?U0 ?U0 ?U0 ?U0HPLC ?U0 ?U0UR4fX&B @ L6D>Pr VH , f6 v>0*Z~ 89t MetolazoneHPLCKromasil CHI-I5 250x4,6mm Hexane/2-Propanol (80/20) UV 230 nm ,Kromasil chiral phases - Application guide1,242 6,5910HPLCKromasil CHI-II 5 250x4,6mm 7Hexane/tert-Butylmethyl ether/Acetic acid (65/35/0,1) UV 220 nm ,Kromasil chiral phases - Application guide1,262 2,4510HPLCKromasil CHI-IIA5 250x4,6mm7Hexane/tert-Butylmethyl ether/Acetic acid (85/15/0,1) UV 215 nm,Kromasil chiral phases - Application guide1,1225,6910,Kromasil chiral phases - Application guide#Daicel application guide 2nde Ed.41 AAAAAAAAAAAAAAAAAABD!t8 X4v@n AAAAAAAAAAAAAAAAAABEd@܅:h@ AAAAAAAAAAAAAAAAAABFTbX9d@!o,6$!3-Amino-epsilon-caprolactamn0000310000325".. t.!.".#.$.%.'.*.).&.(.+.8$0040444000000000009$060666 0!0"0#0$0&0)0(0%0'0*00&+0,08-0888.0/0001020400.60305070 ?U06"02022200000 0 0 0 0 00acd6h 0("|t   n*Xf` hZ<.( 23 NaproxenHPLCKromasil CHI-II 5 250x4,6mm 7Hexane/tert-Butylmethyl ether/Acetic acid (60/40/0,1) UV 270 nm ,Kromasil chiral phases - Application guide2,042 1,961111-Octyl-3-oxo-benzo[D]-isothia(IV)-azole-1-oxid HPLCKromasil CHI-I5 250x4,6mm Hexane/2-Propanol (90/10) UV 220 nm ,Kromasil chiral phases - Application guide1,232 5,3511 OmeprazoleHPLCKromasil CHI-II5P 250x4,6mml>Hexane/2-Propanol/Triethylamine/Acetic acid (92/8/0,15/0,05) UV 300 nmm,Kromasil chiral phases - Application guide1,4 254,7611 OxamniquineHPLCKromasil CHI-I5C 250x4,6mm>Hexane/2-Propanol/Acetic acid/Triethylamine (85/15/0,1/0,05) UV 270 nm1,2623,481115,47n AAAAAAAAAAAAAAAAAABH`(zFwvq@n AAAAAAAAAAAAAAAAAABI#8?Ŗu@n AAAAAAAAAAAAAAAAAABJ8wuq@n000034000036 AAAAAAAAAAAAAAAAAABGt#l@n g$|\ F v2`n$h:\N0" R .v<.( f 68r OxazepamHPLCKromasil CHI-II 5 250x4,6mm Hexane/2-Propanol (85/15) UV 254 nm ,Kromasil chiral phases - Application guide1,352 3,0912&.>/&(,(-(.(/(,,,.,/,.,.-.../.22222666.6/68*8+8,8-8.8<<,<-<.<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&2.>LXdp| $0<HT`lx!+ 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,Kromasil chiral phases - Application guide AAAAAAAAAAAAAAAAAABK\(!q@ 1&24244 42222 2 22 2 2 222&48488844444 4 4 4 4 44244:4:::44444444444 ?W$244:4::: 4!4"4#4$4&4)4(4%4'4*4 ?W$2+4<-4<<<.4/404142444264345474 ?W$ ?W$ ?W$ ?W$ ?U0 ?U0 ?W$U0zl^PB  n hZ<.(  Paraflutizide HPLCKromasil CHI-I5 250x4,6mm 5Hexane/2-propanol/tert-Butylmethyl ether (45/15/40) UV 254 nm ,Kromasil chiral phases - Application guide1,212 5,0412PenflutizideHPLCKromasil CHI-I5 250x4,6mm 4Hexane/2-propanol/tert-Butylmethyl ether (60/5/35) UV 254 nm ,Kromasil chiral phases - Application guide1,232 3,5512PhenprocoumonlHPLCKromasil CHI-II 5a 250x4,6mm/DHexane/2-propanol/tert-Butylmethyl ether/Acetic acid (65/5/30/0,3) UV 310 nmi,Kromasil chiral phases - Application guide1,1524,7712 PriprofenHPLCKromasil CHI-II5C 250x4,6mm7Hexane/tert-Butylmethyl ether/Acetic acid (60/40/0,1) UV 270 nm1,73221,7413 AAAAAAAAAAAAAAAAAABLlHL,g~]y@ AAAAAAAAAAAAAAAAAABM!H?_8x@ AAAAAAAAAAAAAAAAAABN%*-9q@ AAAAAAAAAAAAAAAAAABOt`(5vo@000039000040 ?U0080ppb |pB v2`n$hX6 RDN*x@2, 78vPromethazineHPLCKromasil CHI-II 5 250x4,6mm =Hexane/2-Propanol/Acetic acid/Triethylamine (98/1/0,3/0,05) UV 260 nm ,Kromasil chiral phases - Application guide1,322 4,0313,1,1-Spirobi(3H-2,1-benzoxathiol)-3,3-dioneHPLCKromasil CHI-I5 250x4,6mmHexane/2-Propanol (95/5) UV 240 nm,Kromasil chiral phases - Application guide1,6729,2713 TemazepamHPLCKromasil CHI-I5 250x4,6mm4Hexane/tert-Butylmethyl ether/2-Propanol (85/15/1) UV 254 nm,Kromasil chiral phases - Application guide1,1925,431317,14U AAAAAAAAAAAAAAAAAABP#e`Tq@U AAAAAAAAAAAAAAAAAABQD@r3܀q@26<6<<<6666 6 66 6 6 66000043266>6>>>6666666666628@8@@@88888 8 8 8 8 88288@8@@@8888888888 ?U0 ?U0 ?U0 ?U0 ?%1 AAAAAAAAAAAAAAAAAABR!l(yr@2 6 >"6>>>#6$6%6&6'6)6,6+6(6*6-6 ?U0 ?U0%r r d j\V l(Vd^ ^P4& B L @2,| 67xHPLCKromasil CHI-II 5 250x4,6mm 'Hexane/tert-Butylmethyl ether (70/30) UV 254 nm ,Kromasil chiral phases - Application guide1,172 2,0414 MetoprololHPLCChiralcel OD 250x4,6mm ,Hexane/2-Propanol/Diethylamine (80/20/0,1) UV 254 nm #Daicel application guide 2nde Ed. 170,5 1238 Practolol,HPLCChiralcel OD 250x4,6mm ,Hexane/2-Propanol/Diethylamine (80/20/0,1) UV 254 nm#Daicel application guide 2nde Ed.190,517,538 AAAAAAAAAAAAAAAAAABS!\PN+Dq@Trifluoroanthrylethanol AAAAAAAAAAAAAAAAAABT`8[ Ap@ AAAAAAAAAAAAAAAAAABU8ӂ}p@00004628 @8  8!8"8#8%8(8'8$8&8)83&:B:BBB:::: : : :: : :4&::B:BBB::::::::::5&:: B: B:: :!:#:&:%:":$:':6&(:D*:DDD+:,:-:.:0:3:2:/:1:4:7&< D<DDD<<<< < < << < < ?U0HPLC rh xpbH^ \"HVNT <hZ0"  ./ PindololHPLCChiralcel OD 250x4,6mm ,Hexane/2-Propanol/Diethylamine (80/20/0,1) UV 254 nm #Daicel application guide 2nde Ed. 531,5 6 38 PropanololHPLCChiralcel OD 250x4,6mm ,Hexane/2-Propanol/Diethylamine (80/20/0,1) UV 254 nm #Daicel application guide 2nde Ed. 210,5 1538 Carteolol@HPLCChiralcel OD 250x4,6mm Hexane/2-Propanol (9/1)2 UV 254 nmt#Daicel application guide 2nde Ed.@311i1838 AlprenololHPLCChiralcel OD 250x20mmx2,Hexane/2-Propanol/Diethylamine (80/20/0,1) UV 254 nm #Daicel application guide 2nde Ed.171212,538 AAAAAAAAAAAAAAAAAABW!`(J͞5p@ AAAAAAAAAAAAAAAAAABX8X5;p@ AAAAAAAAAAAAAAAAAABY`(>d+o@ AAAAAAAAAAAAAAAAAABV(ܵ| o@000049000050 ?U00 ?U00 ?U00 ?U00 ?U00 ?U00 ?U00 ?U0000069750^PB4& j\. tl^XDRJn`2$ ;=)h Perisoxal HPLCChiralcel OD 250x4,6mm Hexane/2-Propanol (9/1) UV 254 nm #Daicel application guide 2nde Ed. 9 1 7,7 38 Perisoxal HPLCChiralcel OF 250x4,6mm ,Hexane/2-Propanol/Diethylamine (80/20/0,1) UV 254 nm #Daicel application guide 2nde Ed. 12,51 9 38 PindololHPLCChiralcel OD-R10 250x4,6mm1,0 N NaClO4aq./CH3CN (60/40) UV 254 nm25#Daicel application guide 2nde Ed.19,20,511,3391,34 AAAAAAAAAAAAAAAAAABZ!(q@ AAAAAAAAAAAAAAAAAACA!(q@0000530(<< D< D D D<<<<<<<<<<0000543(>>H>HHH>>>>>>>>>>>>4(> F!> F F F">#>$>%>&>(>)>,>+>'>*>-> ?U0 ?U0 ?U0 AAAAAAAAAAAAAAAAAACB(3PJo@1(<<F<FFF <!<"<#<$<&<'<*<)<%<(<+<5(@H@HHH@@@@@ @ @@ @ @ @@2(>F>FFF>>>>> > >> > > >>\ N @ $ ztbZNj v H4B<",^P4&  23 Propranolol HPLCChiralcel OD-R10 250x4,6mm 1,0 N NaClO4aq./CH3CN (60/40) UV 254 nm 25#Daicel application guide 2nde Ed. 22,70,5 1739 Alimemazine HPLCChiralcel OD-R10 250x4,6mm 1,0 N NaClO4aq./CH3CN (60/40) UV 254 nm 25#Daicel application guide 2nde Ed. 24,30,5 22,239TrimepramineHPLCChiralcel OD-R10 250x4,6mm@1,0 N NaClO4aq./CH3CN (60/40)@ UV 254 nm@25#Daicel application guide 2nde Ed.@29,20,5@24,939&2L2666.6/68*8+8,8-8.8<<,<-<.</<@@*@+@,@-@DDD+D,D-D(FHHH+H,H-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 VerapamilHPLCChiralcel OD-R1025 AAAAAAAAAAAAAAAAAACD#e`Tq@ AAAAAAAAAAAAAAAAAACE'Ġ|\q@000056000059 AAAAAAAAAAAAAAAAAACC!`(J͞5p@